A growing number of vaccine makers are expressing concerns about their ability to quickly develop new vaccine candidates against emerging disease threat, such as Zika and Ebola viruses, Stat reported today, based on interviews with pharmaceutical executives, government officials, and infectious disease experts.
The Food and Drug Administration (FDA) yesterday announced that, for now, it won't enforce four rules related to the implementation of the Food Safety Modernization Act (FSMA), a law passed in 2011 that signaled the biggest overhaul in the nation's food safety laws in 70 years.
Health officials in Los Angeles County today announced the area's first sexually transmitted Zika case, which involves a male resident who traveled to Mexico and had Zika symptoms in early November and his female partner, who did not travel.
Also, a study shows that receipt of Dengvaxia may alter the accuracy of dengue tests.
Today the World Health Organization (WHO) updated its Q and A document that covers developments surrounding Dengvaxia, Sanofi's dengue vaccine. It says its Strategic Advisory Groups of Experts (SAGE) will undertake a full rigorous view of new data to update its position paper on the vaccine, which won't likely be available until after April 2018.
President Donald Trump today released a new foreign strategy called the "America First" document, outlining his administration's geopolitical goals. In addition to naming Russia and China as America's "rivals," the president dedicates less than 1 page of the 68-page document to the threats posed by biological weapons.
Data show that about 4 of 1,000 seronegative patients vaccinated could develop ADE, a serious side effect.
A new report from Reuters concerning previously unreleased documents shows that the Philippines Department of Health (DOH) implemented a childhood vaccine campaign with Dengvaxia despite warnings from the country's Formulary Executive Council (FEC) that the vaccine did not have enough long-term safety data.
The Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV in Sakaka, a city in the northwestern corner of the country.
A 64-year-old Saudi man is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. His source of infection is listed as "primary," meaning it's unlikely he contracted the virus from another person.
A leading dengue vaccine researcher says the move is not surprising, while Sanofi says antibody-dependent enhancement cannot be the whole story surrounding vaccine performance.
